Hemogenyx Pharmaceuticals (HEMO) Finalizes CAR-T Collaboration with Cellin Technologies for HG-CT-1 Therapy in Estonia

Hemogenyx Pharmaceuticals (HEMO) Finalizes CAR-T Collaboration with Cellin Technologies for HG-CT-1 Therapy in Estonia →

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the London-based clinical-stage biopharmaceutical company, has formalized a definitive Collaboration Agreement with Estonian cell therapy specialist Cellin Technologies OÜ for the manufacturing and…